|
|||
|
|||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
||||||||
 |
 |
 |
||||||
 |
||||||||
 |
 |
 |
||||||
 |
||||||||
 |
 |
 |
||||||
 |
||||||||
 |
|
 |
||||||
 |
||||||||
 |
 |
 |
||||||
 |
||||||||
 |
 |
|||||||
|
|
|
|
|
|
|
|
|
|
 |
|
 | |
|
Jack Antel, MD
Professor of Neurology McGill University School of Medicine Jack Antel, MD, is a clinical neurologist who coordinates the multiple sclerosis research and treatment programme at the Montreal Neurological Institute. He is a professor at McGill University where he has served as chairman of the department of neurology and neurosurgery. He is currently director of the Canadian Institute of Health Research–supported training program in neuro-inflammation and has just completed his term as president of the International Society of Neuroimmunology. Dr. Antel was appointed chairman of the medical advisory board of the Multiple Sclerosis Society of Canada in January 2004. He was the recipient of the 2005 Dystel Award from the National Multiple Sclerosis Society and the American Academy of Neurology. Prior to is work at McGill, Dr. Antel was a professor of neurology at the University of Chicago.
Brian R. Apatoff, MD, PhD
Brian R. Apatoff, MD, PhD, is the director of the Multiple Sclerosis Clinical Care and Research Center at New York Presbyterian Hospital and Cornell Medical College. He is a clinical attending and associate professor in the department of neurology and neuroscience. Dr. Apatoff received his MD and PhD degrees from the University of Chicago Pritzker School of Medicine. He did his medical training at the Brigham and Women's Hospital and Harvard Medical School, and then completed his neurology residency at the Neurological Institute of Columbia-Presbyterian Medical Center, where he served as chief resident. He then performed a National Multiple Sclerosis Society Research Fellowship at Columbia University College of Physicians and Surgeons and the Scripps Research Institute and Clinic. Dr. Apatoff serves on the clinical advisory committee of the National Multiple Sclerosis Society, and is the recipient of a Clinical Investigator Development Award from the National Institutes of Health, National Institute of Neurological Disease and Stroke.
Douglas L. Arnold, MD
Douglas L. Arnold, MD, is the James McGill Professor in the department of neurology and neurosurgery at McGill University, and he is the director of the magnetic resonance spectroscopy unit and the clinical research unit at the Montreal Neurological Institute. Dr. Arnold received his BSc from McGill University in Montreal and his MD from Cornell University Medical College in New York City. After medical school he returned to McGill University for residency training in internal medicine and neurology. His training in magnetic resonance spectroscopy was obtained at the University of Oxford in the early 1980s when the in vivo applications of this technique were just being developed. He then returned to Montreal to join the staff of the Montreal Neurological Institute and McGill University where he has developed the use of MR spectroscopy and other advanced MRI imaging techniques for the investigation of neurological disorders. In recent years Dr. Arnold has been using advanced magnetic resonance imaging techniques to investigate how the disease multiple sclerosis progresses and the extent to which it causes brain damage.
Rohit Bakshi, MD
Rohit Bakshi, MD, FAAN, is an associate professor of neurology at Harvard Medical School, neurologist and neuroimager at Brigham and Women's Hospital, director of clinical MRI/MS imaging at the Partners Multiple Sclerosis Center, and researcher at the Center for Neurological Imaging. A Buffalo native and graduate of Cornell University, he received his MD from the SUNY University at Buffalo. As an Alpha Omega Alpha scholar, he completed a one-year neuroscience research fellowship with Dr. Alan Faden at the University of California, San Francisco. He served a one-year internship at the Massachusetts General Hospital and Harvard Medical School followed by a neurology residency at UCLA, where he performed neuroimaging research with Dr. John Mazziotta. He then completed a one-year MRI/CT neuroimaging fellowship at the Dent Neurologic Institute followed by continuing training in functional imaging and brain mapping, including PET and SPECT. Dr. Bakshi is board-certified in neurology and certified in MRI-CT by the American Society of Neuroimaging. He previously served on the faculty at the University at Buffalo-SUNY, where he rose to the rank of Associate Professor of Neurology with Tenure and was Residency Program Director. He was the founding director of the Buffalo Neuroimaging Analysis Center (BNAC), neurologist and neuroimager, and multiple sclerosis specialist at the Dent Neurologic Institute, the Jacobs Neurological Institute, and Physicians Imaging Centers. In building his research program at the BNAC, he pursued studies of quantitative MRI in MS, funded by the National Institutes of Health, National Science Foundation, and National MS Society. He received the 1998 William H. Oldendorf Award for neuroimaging research. He is a member of the American Neurological Association, has achieved fellow status in the American Academy of Neurology, and is a grant reviewer for NIH. He serves on the editorial board of The Journal of Neuroimaging and as associate editor of NeuroRx. He is the president of the American Society of Neuroimaging. He has delivered more than 100 invited lectures and has authored more than 300 publications, including print and online articles and abstracts, more than 110 of which are peer reviewed articles. His work has appeared in a variety of journals such as The New England Journal of Medicine, The Journal of Neuroscience, Neurology, NeuroImage, AJNR: American Journal of Neuroadiology, Annals of Neurology, The Journal of Computer Assisted Tomography, NeuroReport, Multiple Sclerosis, Archives of Neurology, Brain Research, The Journal of Neurology Neurosurgery and Psychiatry, and Medscape.
Khurram Bashir, MD, MPH Dr. Khurram Bashir earned his MD and his BS in medicine from King Edward Medical College in Lahore, Pakistan. He obtained his MPH in epidemiology from the University of Alabama at Birmingham. He completed an internal medicine internship at Southern Illinois University at Springfield as well as a combined internal medicine and neurology residency. He completed a neuroimmunology and multiple sclerosis fellowship under the leadership of Dr. John N. Whitaker at the University of Alabama at Birmingham department of neurology, and currently serves as an assistant professor of neurology there. Today Dr. Bashir is the director of the neuroimmunology and multiple sclerosis division within the department of neurology and is director of the Multiple Sclerosis Center at the University of Alabama at Birmingham. He also serves as medical director for the Multiple Sclerosis Clinic at Birmingham's Veterans' Medical Center, for the National MS Society Second Opinion Clinic for the University of Alabama at Birmingham, and for the National MS Society, Alabama Chapter.
Ralph H. B. Benedict, MD
Ralph H. B. Benedict, MD, is an associate professor of neurology and psychiatry at the State University of New York at Buffalo School of Medicine, director of the SUNY Buffalo clinical neuropsychology residency program, and head of the clinical neuropsychology section in the department of developmental and behavioral neurosciences. Dr. Benedict received his bachelor's degree in psychology from the Ohio State University and then went on to Arizona State University where he completed both masters and doctorate degree programs in clinical psychology. He also finished a postdoctoral fellowship in clinical neuropsychology at the Johns Hopkins School of Medicine. Dr. Benedict is board certified in clinical neuropsychology by the American Board of Professional Psychology. Dr. Benedict is a member of numerous societies and associations including the American Psychological Association, the National Academy of Neuropsychology, and the International Neuropsychological Society. He is an ad hoc reviewer for numerous medical journals. He has published over 39 articles in peer-reviewed journals and over 10 book chapters.
Dennis Bourdette, MD
Dennis Bourdette, MD, is the interim chairman and Roy and Eulalia Swank Family Research Professor in the department of neurology at Oregon Health and Science University (OHSU) and director of the Multiple Sclerosis Center of Oregon. He received his medical degree from the University of California at Davis, School of Medicine, completed his neurology residency at OHSU and was a post-doctoral fellow in neuroimmunology at the Portland VA Medical Center. He has participated in many of the pivotal trials of recombinant interferon-beta and glatiramer acetate. His area of special interest is the immunopathogenesis and treatment of multiple sclerosis and other neuroimmunologic diseases.
Ted Brown, MD, MPH Ted R. Brown, MD, MPH, attended Harvard Medical School and completed his internship and residency in physical medicine and rehabilitation at the University of Washington. From 1993-2002, he worked at a rehabilitation center in northern Thailand, where most of the rehabilitation cases were leprosy, stroke, or road traffic injury victims. In 2002, Dr Brown obtained a Masters of Public Health at the University California. Berkeley and then did a one-year clinical fellowship in MS at the University of Washington under the direction of George Kraft, MD, and James Bowen, MD. Dr Brown practiced at the MS hub in Seattle until this year. Currently, he works at the Multiple Sclerosis Center at Evergreen Hospital Medical Center in Kirkland, Washington. Dr Brown participates in many National Multiple Sclerosis Society patient education events and as the principle investigator of several ongoing studies. His research interests are in fatigue, ambulation, and exercise in MS.
Jack S. Burks, MD
Jack S. Burks, MD, is a clinical professor of neurology at the University of Nevada School of Medicine and president of the MS Alliance, a nonprofit organization dedicated to helping people affected by multiple sclerosis. He is a founder of the Consortium of MS Centers, the MS Council and the American Society of Neurorehabilitation. Dr. Burks was appointed to the medical advisory board of the National MS Society and has previously served on the board of directors of the American Academy of Neurology. He is the senior editor of the textbook Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation. His research interests include generating models for lifelong care (disease management) and identifying complimentary or alternative treatments of MS. He has been involved in many clinical trials involving MS patients. Dr. Burks speaks frequently to health care professionals and people affected by MS.
Peter Calabresi, MD
Peter Calabresi, MD, is an associate professor of neurology and director of the Johns Hopkins Multiple Sclerosis Center. He specializes in the diagnosis and management of multiple sclerosis. As director of the MS clinic, Dr. Calabresi is the principal investigator on several clinical trials and also oversees translational laboratory research projects. Dr. Calabresi has designed and directed several clinical trials investigating combination drug therapies in MS. He is on the advisory board for three national multi-center clinical trials.
Tanuja Chitnis, MD
Tanuja Chitnis, MD, is an assistant professor of neurology at Harvard Medical School and an associate neurologist at Brigham and Women's Hospital. She is the director of the Partners Pediatric Multiple Sclerosis Center at Massachusetts General Hospital. Dr. Chitnis earned her BS in microbiology and MD at the University of Toronto. She held her residency in neurology at Hahnemann University Hospital and a fellowship in neuroimmunology at Brigham and Women's Hospital. David B. Clifford, MD
David M. Clifford, MD, is the Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology and Professor of Medicine. He received his BA summa cum laude in chemistry and history from Southwestern University and his MD from Washington University School of Medicine. He completed residency programs in medicine and neurology at Barnes Hospital in St. Louis and served as postdoctoral fellow in neurology before becoming appointed as a research instructor in neurology. Dr. Clifford has assumed positions of leadership in the medical school, including chairing the executive committee of the faculty council, faculty clinical representative to the faculty practice plan, and serving on numerous committees. Board-certified in psychiatry and neurology (neurology), Dr. Clifford has served as president of the medical staff of St. Louis ConnectCare, the corporation providing indigent health care in the St. Louis region and as medical director of neurology for Barnes Jewish Hospital. On a national basis, Dr. Clifford has chaired the neurology section of the AIDS Clinical Trials Group, served on the scientific program committees for the American Academy of Neurology and for the Conference on Retroviruses and Opportunistic Infections, as a counselor for the American Neurological Association, chairs the external advisory committee for the National NeuroAIDS Tissue Consortium and is a member of the American Federation for AIDS Research scientific advisory board. He sits on the editorial boards of The Journal of NeuroVirology and NeuroAIDS and is a frequent ad hoc reviewer for the major neurologic journals. He is listed in "Best Doctors in the US." Dr. Clifford is the principal investigator of the NINDS-supported Neurologic AIDS Research Consortium (NARC), a national group including over 20 medical centers that organizes and supports clinical trials for HIV neurologic complications. In addition, Dr. Clifford has participated in pharmacologic investigations in Parkinson's disease and multiple sclerosis. He is also the principal investigator for the Washington University AIDS clinical trials unit organized to lead translational research relevant to HIV/AIDS. Patricia Coyle, MD
Patricia Coyle, MD, is a professor of neurology and director of the Stony Brook Multiple Sclerosis Comprehensive Care Center. Her areas of expertise include neurologic infectious disease, in particular Lyme disease, and MS. Dr. Coyle received her medical degree from the Johns Hopkins School of Medicine. She then went on to complete her residency in Neurology and a fellowship in neurovirology and immunology also at Johns Hopkins. Dr. Coyle has received funding from the National Institutes of Health and National MS Society, among other organizations. She is actively engaged in MS therapeutic trials and studies to elucidate neurologic Lyme disease. She is a member of many committees of the American Academy of Neurology, American Neurological Association and National Multiple Sclerosis Society and has been an expert adviser to the Food and Drug Administration. In addition to lecturing around the country on neurologic topics, Dr. Coyle has a busy clinical and research practice, and in addition maintains a research laboratory.
Heidi J. Crayton, MD Heidi J. Crayton, MD, is an MS specialist at the Georgetown University Multiple Sclerosis Center in Washington, DC. She received her BS in kinesiology from the University of California at Los Angeles. She went on to earn her MD from the Medical College of Pennsylvania in Philadelphia. She completed her residency in adult neurology at Georgetown University Hospital and the VA Medical Center in Washington, DC. Dr. Crayton has been awarded for her work in medical student teaching. She is involved in research for the treatment of people with multiple sclerosis and currently runs the MS Center at Georgetown University Medical Center. She is affiliated with the American Academy of Neurology, the Consortium of Multiple Sclerosis Centers, and is on the professional advisory committee for the national capital chapter of the National Multiple Sclerosis Society. Dr. Crayton has been involved in national and international conferences on the advancement of treatment and care in MS. She has spoken nationally to physician and patient groups on the topic of MS.
Dorothy Anne Cross, MD
Dorothy Anne Cross, MD, is associate professor of neurology at the Washington University School of Medicine and is co-director of the Washington University Multiple Sclerosis Clinic. She is board certified in neurology. Dr. Cross earned her undergraduate degree in chemistry from the University of South Alabama, graduating summa cum laude. She then graduated cum laude from the University of Alabama School of Medicine. She completed her internship training in internal medicine at the Mercy Hospital and Medical Center in San Diego after which she completed her residency in neurology at George Washington University in Washington, DC. Dr. Cross's post-graduate training includes a medical staff fellowship at the Neuroimmunology Branch of the NIH, a Levy Fellowship in the Department of Virology and Molecular Biology at the St. Jude Children's Research Hospital in Memphis, and a Fellowship of the National Multiple Sclerosis Society in the department of pathology at the Albert Einstein College of Medicine. Dr. Cross has written numerous articles for publication in peer-reviewed journals. She sits on the editorial boards of the journals Neurology and Journal of Neuroimmunology. Her clinical interests include multiple sclerosis, experimental autoimmune encephalomyelitis, autoimmune demyelination, and lymphocyte-endothelial cell adhesion.
Robert Fox, MD
Dr. Fox is Staff Neurologist and Medical Director at the Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation. He received medical degree from Johns Hopkins University and neurology residency training at the Hospital of the University of Pennsylvania. His research training and experience includes a master's degree in Clinical Research from Case Western Reserve University, a Potiker Fellowship in Multiple Sclerosis at the Mellen Center, site principal investigator for many clinical trials, and principal investigator and co-investigator on NIH and National MS Society-funded grants. Dr. Fox is also a member of the Clinical Advisory Committee for the Ohio Buckeye Chapter of the National MS Society and the General Advisory Council for the Cleveland Clinic General Clinical Research Center. His current research interests focus on innovative MRI techniques to evaluate MS treatments and tissue recovery after injury.
Elliot Frohman, MD, PhD
Elliot Frohman, MD, PhD, is an associate professor of neurology and ophthalmology, holder of the Kenney Marie Dixon-Pickens Distinguished Professorship in Multiple Sclerosis Research and the Irene Wadel and Robert Atha Distinguished Chair in Neurology and director of the multiple sclerosis program and of the Vertigo and Eye Movement Clinics in the department of neurology at the University of Texas Southwestern Medical Center. Dr. Frohman was born in New York City and received his undergraduate training in biochemistry and cell biology at the University of California at San Diego and later completed the physician scientist training program for his MD and PhD degrees at the University of California at Irvine. Dr. Frohman subsequently completed his residency and fellowship training in neurology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital where he is a former chief resident. He is board certified in psychiatry and neurology. Dr. Frohman has been the recipient of numerous awards and fellowships and has published papers in the areas of neuroimmunology and neuro-ophthalmology. He is a member of the therapeutics and technology assessment committee of the American Academy of Neurology. Recently he was the recipient of a United States Congressional Appropriations Bill to establish a comprehensive multiple sclerosis treatment training program at the University of Texas Southwestern School of Medicine in collaboration with the National Multiple Sclerosis Society. He serves as an ad hoc reviewer for numerous journals including The Annals of Neurology, Neurology, Archives of Neurology, Journal of Neurological Sciences, Journal of Neuroimmunology, and Neuro-Ophthalmology. Dr. Frohman is married to Teresa Frohman. They have four children and live in Coppell, Texas.
Steven L. Galetta, MD
Steven L. Galetta, MD, is currently the Van Meter Professor of Neurology and a member of the Multiple Sclerosis Division at the University of Pennsylvania School of Medicine. He is also the director of the Neuro-Opthamology Division and the neurology training program. After earning his Bachelor's degree from the University of Pennsylvania and his medical degree from the Cornell University Medical College, Dr. Galetta returned to Philadelphia where he completed his residency in neurology at the Hospital of the University of Pennsylvania. He then went on to complete a fellowship in neuro-ophthalmology at the Bascom Palmer Eye Institute in Miami, Florida. Dr. Galetta is board certified in neurology and neuro-ophthalmology. Dr. Galetta is published in several top medical journals and has been named one of the "Best Doctors in America" on numerous occasions. He is a member of the American Neurologic Association, American Academy of Neurology, the Stroke Council, the Frank B. Walsh Society, and the North American Neuro-Ophthalmology Society.
Andrew D. Goodman, MD Andrew D. Goodman, MD, is an associate professor of neurology, chief of the neuroimmunology unit, and director of the Multiple Sclerosis Center at the University of Rochester Medical Center in Rochester, New York. A graduate of Rutgers College and the University of Medicine and Dentistry of New Jersey, he did residency training in internal medicine and neurology at Mount Sinai Medical Center in New York City. Dr. Goodman completed a research fellowship in the neuroimmunology branch at the National Institutes of Health. Numerous publications reflect his interests in the immunology and virology of multiple sclerosis as well as clinical and experimental therapeutics research. Dr. Goodman is a past chair of the multiple sclerosis section of the American Academy of Neurology. He currently serves the National Multiple Sclerosis Society as deputy medical officer, chair of the long-term care committee, and member of the executive committee of the medical advisory board.
Jeffrey I. Greenstein, MD
Jeffrey Greenstein, MD, is currently chairman and professor of neurology at Temple University School of Medicine and is the director of the Multiple Sclerosis Center at Temple University Hospital in Philadelphia, PA. Dr. Greenstein received his medical degree from the University of Cape Town in South Africa and completed his residency in neurology and his fellowship in neuropathology at Cleveland Metropolitan General Hospital in Cleveland. Dr. Greenstein is board certified in neurology. Dr. Greenstein's research interests include the regulation of immune responses to self antigens to MS, functional neuroimaging of gait disorders, and experimental immunotherapy in multiple sclerosis. Dr. Greenstein is widely published in scientific and neurology journals and sits on the board of trustees of the National Multiple Sclerosis Society.
Francisco González-Scarano, MD
Francisco González-Scarano, MD, is a professor and chairman of the department of Neurology at the University of Pennsylvania School of Medicine. He is also Co-Director of the University of Pennsylvania Center for HIV and AIDS Research. Dr. González-Scarano earned his BA in Economics at Yale University in New Haven and his MD at Northwestern University in Chicago. He completed his internship and residency at the University of Pennsylvania, and has completed post-doctorate work at the University of Pennsylvania and the National Institute for Medical Research in London. Dr. González-Scarano is a past chairman of the National Institute of Neurologic Disorders and Stroke (NINDS) Board of Scientific Counselors, and served on the AIDS and Related Research Group (ARRG) Study Section 5. He is also a past chairman of the NINDS Non-Neuronal Cell Panel. He is the author or co-author of over 130 peer-reviewed publications.
Douglas Goodin, MD
Douglas Goodin, MD, is an associate professor of neurology at the University of California, San Francisco and director of the Multiple Sclerosis Center at UCSF. Dr. Goodin received his medical degree from Purdue University after which he completed an internship in internal medicine at the University of California, Irvine and a residency in neurology at the University of California, San Francisco. He is board certified by the American Board of Psychiatry and Neurology, the American Board of Clinical Neurophysiology, and the American Board of Electrodiagnostic Medicine. Throughout his medical career, Dr. Goodin has been actively involved in a number of associations and societies. He sits on the Board of the American Board of Clinical Neurophysiology. He is an American Academy of Neurology Representative to the MS Council for Clinical Practice Guidelines. He is a member of the board of directors of the National Multiple Sclerosis Society, Northern California Chapter. He also serves on the editorial boards of Electroencephalography and Clinical Neurophysiology, Seminars in Multiple Sclerosis, the Journal of Clinical Neurophysiology, and Muscle and Nerve. He has published over 85 papers and 20 book chapters.
Dina A. Jacobs, MD
Dina Jacobs, MD, is an assistant professor of neurology at the University of Pennsylvania School of Medicine in Philadelphia. Her interests are in multiple sclerosis, neuro-ophthalmology, and women's health. Dr. Jacobs earned her BA in Natural Science and Spanish as well as her MD, at the University of Pennsylvania. She completed her internship, residency, and fellowships in multiple sclerosis and neuro-ophthalmology at the University of Pennsylvania. Dr. Jacobs is a member of the American Academy of Neurology and the Philadelphia Neuro-Ophthalmology Society. In addition to being the author or co-author of numerous publications and lectures, she has served as an Associate Editor for The Amercian Journal of Ethics and Medicine. >
Douglas R. Jeffery, MD Douglas Jeffery, MD, PhD, completed his undergraduate studies at the University of Maryland, College Park, Maryland. He earned his PhD in pharmacology and therapeutics from the State University of New York School of Medicine in Buffalo, New York, in 1983. He earned his medical degree from the same institution in 1987. Dr Jeffery completed his internship program at the State University of New York in Buffalo. He completed his residency in neurology at the University of New Mexico. Dr Jeffery served as a staff physician and instructor for the Department of Neurology and Spinal Cord Injury Unit at the Veterans Administration Medical Center and the University of New Mexico from July 1992 to December 1993. He has been an assistant professor in neurology at the Wake Forest University School of Medicine since January 1994. He was certified in neurorehabilitation through the American Society of Neurorehabilitation in March of 1994 and board certified in neurology in June 1994. Dr Jeffery's area of clinical and research interest is MS. His current grant support includes Teva Marion's Evaluation of Injected Glatiramer Acetate in Primary Progressive Multiple Sclerosis, Teva Marion's Evaluation of Oral Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis, Pfizer's Evaluation of Donepezil in the Treatment of Cognitive Dysfunction in Multiple Sclerosis, Immunex and Berlex's Evaluation of Mitoxantrone in Treatment of Multiple Sclerosis, and Elan's Evaluation of Zanaflex Modified Release in the Treatment of Spasticity in Multiple Sclerosis and Spinal Cord Injury.
Michael Kaufman, MD
Michael Kaufman, MD, is a clinical neurologist with an interest in multiple sclerosis clinical research since 1993. After attending Union College, Dr. Kaufman received an MD degree from Duke Medical School. His post-graduate training was performed at Cornell's The New York Hospital, Case-Western Reserve's Cleveland Metropolitan General Hospital, and The Mayo Clinic. Dr. Kaufman held faculty positions at Emory School of Medicine and Duke Medical School before a 14-year career in the private practice of neurology. In 1993 he left private practice and joined the staff of Carolinas Medical Center, where he organized the first MS clinical research center in North or South Carolina. This Center has conducted more than 15 randomized, double blind, placebo-controlled clinical trials in MS and has contributed over 20 articles, abstracts, and book chapters to the MS literature. Dr. Kaufman has been selected as Professional of the Year and chosen for the Leadership Award by the Mid-Atlantic Chapter of the National Multiple Sclerosis Society. He has also served on its board of directors and clinical advisory committee.
Samia Khoury, MD Semia Khoury, MD, received her medical diploma from the American University of Beirut, Lebanon in 1984 having been elected to the Alpha Omega Alpha Honor Medical Society in 1983. She completed her neurology residency at the Case Western Reserve University Hospitals in Cleveland, Ohio in 1988. She then came to the Brigham and Women's Hospital as a research fellow at the Center for Neurologic Diseases. In 1991, after the completion of her fellowship, she was appointed instructor in medicine and then assistant professor of neurology in 1994. In 1998 she was promoted to associate professor of neurology, and was also appointed as the director of the Clinical Immunology Laboratory at the Center for Neurologic Diseases at Brigham and Women's Hospital. In 2001, she was additionally appointed as the co-director of the Partners Multiple Sclerosis Center, Boston. Her accomplishments are summarized in three areas: 1) A well funded basic research program that addresses clinically relevant questions in MS; 2) Expertise in mechanistic studies complementing cutting edge clinical research; 3) Expertise in running a first rate clinical program for MS. Dr. Khoury has been well funded since establishing her laboratory and has maintained continuous funding through the NIH and the National Multiple Sclerosis Society. Her stature in translational research is evident in her ability to secure NIH funding for basic research as well as receiving an Autoimmunity Centers of Excellence award (U19) for clinical trials/mechanistic studies. Dr. Khoury's commitment to translational research is evident by her involvement in clinical trials at the MS center. Her major interest in this regard is the performance of Phase I and II trials with mechanistic studies. She is the principal investigator of 3 trials funded by the NIH heavily emphasizing mechanistic studies.
R. Philip Kinkel, MD
R. Philip Kinkel, MD, is the director of the multiple sclerosis program at Beth Israel Deaconess Medical Center and an associate professor of neurology at Harvard Medical School. He is a member of the National Medical Advisory Board of National Multiple Sclerosis Society, a member of one of the NMSS scientific study sections, current or past chairman of several multi-center clinical trials and a reviewer for several medical journals. His publications reflect a longstanding interest and expertise in issues directly related to the clinical management of MS and related conditions. He is currently the study chairman of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in On-going Neurologic Surveillance (CHAMPIONS), a long term multi-center study to assess the natural history of MS treated from the onset of first symptoms, prior to a definitive diagnosis.
Mariko Kita, MD Dr. Kita attended medical school at the Northwestern University School of Medicine, her residency in neurology at the Hospital of the University of Pennslyvania, internship in internal medicine at Northwestern Memorial Hospital, and a fellowship in neuroimmunology at Mt. Zion Multiple Sclerosis Center, University of California School of Medicine. Dr. Kita is currently Director of the Virginia Mason Multiple Sclerosis Center and is board certified by the American Board of Psychiatry and Neurology
Igor J. Koralnik, MD Igor J. Korlanik, MD, is an associate professor of neurology at Harvard Medical School, and director of the HIV/Neurology Center at Beth Israel Deaconess Medical Center. Dr. Korlanik earned his MD at the University of Geneva Medical School, and he held his internship and residency in internal medicine at Geneva University Hospital. Dr. Koralnik conducted his residency in neurology in the Harvard-Longwood Neurology Training Program at Harvard Medical School, and a post-doctoral fellowship in molecular biology of retroviruses at the National Institutes of Health. With specialties in neuro-infectious diseases and neuroAIDS, Dr. Koralnik is the author of numerous peer-reviewed publications. The focus of Dr. Koralnik's research program is progressive multifocal leukoencephalopathy and its etiologic agent, the polyomavirus JC.
Joseph R. Lacy, MD
Eugene O. Major, Ph.D.
Eugene O. Major, PhD, received his PhD degree from the University of Illinois Medical Center in infectious diseases and microbiology and was a part of a team that established a research center there on the genetics of viruses that caused cancer. Following academic appointments as associate professor at the University of Illinois Medical School and the Loyola University Medical School and as an associate dean of graduate programs, Dr. Major joined the National Institute of Neurological Disorders and Stroke at the NIH in 1981. He has developed a basic research laboratory in the intramural program focusing on mechanisms of viral pathogenesis in the human nervous system which includes JC Virus induced demyelination, progressive multifocal leukoencephalopathy, and HIV-1 associated encephalopathy. As chief of the laboratory of molecular medicine and neuroscience, Dr. Major's investigations focus on the biology of virus infections in nervous system cells derived from the human developing brain and the molecular regulation which controls viral gene expression. Dr. Major has received the NIH Merit Award for his work on PML as well as NIH recognition for distinguished service in studies on the consequences of HIV-1 infection in the human nervous system. Dr. Major has recently been elected to the Academy of Neurosciences in India; he is a member of the board of directors of People to People, the Ethiopian non-Governmental Organization on AIDS; and he is an elected, active member of the American Neurological Association ANA. Dr. Major also holds a number of US and international patents on unique cell lines developed from the human central nervous system which can be applied to transplantation therapies for neurodegenerative diseases. Dr. Major's laboratory maintains extensive collaborations with clinical colleagues and participates in clinical trials as a basic science laboratory as a certified CLIA laboratory which also supports FDA regulatory studies. Dr. Major's work has been published in over 180 papers as well as numerous text and review books. Dr. Major is a founding member of the International Society for Neurovirology and The Journal of NeuroVirology, and he is an adjunct professor at the George Washington University School of Medicine. Dr. Major is the coordinator for AIDS research in the NINDS Intramural Program and has served as the acting deputy director of the NINDS for two years, as the basic neuroscience program director of the intramural program, and as the co-chair of the White House Office of Science and Technology Policy Intra-Agency Committee on Prion Science.
Clyde E. Markowitz, MD
Clyde E. Markowitz, MD is Director of the MS Center at the Hospital of the University of Pennsylvania. and is an assistant professor of neurology at the University of Pennsylvania School of Medicine in Philadelphia. He earned his MD from the Columbia University College of Physicians and Surgeons. He also completed residency, postdoctoral research and clinical fellowship at the Neurological Institute at Columbia University College of Physicians and Surgeons in New York. His expertise is in the field of Multiple Sclerosis and is involved with many clinical trials developing new compounds for the treatment of MS. His research interests include utilization of new MRI techniques to study the pathogenesis of MS and has a great interest in the immunology of MS. He currently serves as the Chairman of the Clinical Advisory Committee for the Delaware Valley chapter of the National Multiple Sclerosis Society. Dr. Markowitz is the author or co-author of a number of publications, and he serves as an ad hoc reviewer for Multiple Sclerosis, Neuro-Rehabilitation, Neural Repair, Journal of Clinical Immunology, and The Consultant. Dr. Markowitz is a member of the American Academy of Neurology.
Colleen E. Miller, RN, NP, DNS
Colleen Miller, RN, NP, DNS, is a nurse practitioner at the Jacobs Neurological Institute and the William C. Baird Multiple Sclerosis Research Center. For over a decade she worked closely with Dr. Lawrence Jacobs in the areas of clinical research and in the care of patients with MS. She is a graduate of Niagara University, the State University of New York at Buffalo, and the University of Rochester. Her credentials include a BS in nursing, a MS as a critical care clinical nurse specialist, a postmaster's certification as an adult nurse practitioner in neurology, and a doctorate of nursing science. Dr. Miller is an international MS nurse expert and one of the founding members of the International Organization of MS Nurses. She is also the recipient of the 2002 State University of New York at Buffalo Alumni of Distinction Award as well as the National MS Society's 2002 Stephen J. Kelly award for dedicated service to people with MS. Dr. Miller holds positions at the State University of New York at Buffalo as an Adjunct Professor in the School of Nursing and a Clinical Instructor in the School of Medicine and Biomedical Sciences. Finally, but most importantly, Dr. Miller is the wife of Eric and mother of Alyson and Nicholas Miller.
James Miller, MD
James Miller, MD, is an associate professor of clinical neurology at the Columbia University College of Physicians and Surgeons and is director of the Multiple Sclerosis Clinical Care Center at the New York Presbyterian Hospital at Columbia Presbyterian Medical Center. Dr. Miller received his medical degree from the New York University School of Medicine. He then went on to do his internship in internal medicine at the New York University Medical Divisions, Bellevue Hospital and his residency in neurology at the New York Neurological Institute at the Columbia Presbyterian Medical Center. He also completed a special fellowship in neurovirology at the Rockefeller University in New York City. He is board certified in neurology. Dr. Miller's major research interests are multiple sclerosis and central nervous system infections. He has received a number of honors and awards in these areas including a Cardin Fellowship in Immunology and Virology of the Romill Foundation and a Fulbright Visiting Lecturer in Neurovirology (India). He has published over 40 articles and book chapters. Dr. Miller also has a number of important administrative responsibilities at CPMC including the institutional review board, the pharmacy and therapeutics committee, and the department of neurology executive committee of the faculty.
Frederick E. Munschauer III, MD
Frederick E. Munschauer III, MD, is the director of the Research Center for Stroke and Heart Disease at Kaleida Health in Buffalo, NY, and his primary research interests are vascular disease prevention, healthcare delivery, and multiple sclerosis. Dr. Munschauer is involved in a number of clinical trials funded by the National Institutes of Health as well as the pharmaceutical industry. His research has been published in Clinical Therapeutics, Stroke, Neurology, and Annals of Neurology. Dr. Munschauer is an associate professor of clinical neurology and internal medicine at the State University of New York at Buffalo School of Medicine.
Marie A. Namey, RN, MSN
Marie A. Namey, RN, MSN, received her MSN from Frances Payne Bolton School of Nursing at Case Western Reserve University. She received her BS in nursing from Villa Maria College, Erie, Pennsylvania. Ms. Namey has been part of the interdisciplinary team at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic Foundation since its inception in 1985. She is a member of the local MS Society Chapter Professional Advisory Committee and the Chapter Program Committee. She is a popular speaker for patient and professional groups on aspects of MS care. Ms. Namey is a member of Advisory Groups for pharmaceutical companies. She is on the editorial board for Real Living with MS. She has published on topics of bladder and bowel function and adherence. She has been a member of the Consortium of Multiple Sclerosis Centers 1986 and has served as secretary, vice president and president of this organization. She was chair of the education committee and participated on the education committee and abstract review committee. She currently chairs the advocacy committee. Ms. Namey is a founding member and currently is Treasurer of the International Organization of Multiple Sclerosis Nurses (IOMSN).
Paul O'Connor, MD, MSc
Paul O'Connor, MD is the director of the MS Clinic at St. Michael's Hospital and director of the MS program at the University of Toronto. He also serves as director of the division of neurology at St.Michael's Hospital, University of Toronto. Dr. O'Connor's research interest is in the development of new treatments for MS and in that capacity has served on the steering committee for numerous drug trials with various roles including chairman. He has numerous peer-reviewed publications on this subject and remains very active in the field.
Joel Oger, MD
Joel Oger, MD, is a professor of neurology at the University of British Columbia School of Medicine. He is an associate member of the department of pathology and laboratory medicine.
Andrew Pachner, MD
Andrew Pachner, MD, is a professor of neurosciences at the University of Medicine and Dentistry of New Jersey.
Micheal D. Phillips, MD Micheal D. Phillips, MD, is the section head for the section of imaging sciences in the division of radiology at the Cleveland Clinic. He is also affiliated with a number of other Cleveland-area medical facilities. After completing his undergraduate studies at Amherst College, Dr. Phillips went on to study medicine and earn his MD from Columbia University. Subsequently, he did a radiology residency at Johns Hopkins Hospital and a neuroradiology fellowship at the University of Pennsylvania. Dr. Phillips serves as a reviewer for several imaging journals, he has authored or co-authored numerous articles and book chapters. He is a practicing clinical neuroradiologist and imaging researcher at the Cleveland Clinic. His research endeavors are primarily centered on functional MR imaging of neurodegenerative processes, particularly multiple sclerosis and Parkinson's disease. The underlying goal of his imaging research is to develop functional metrics to better understand and more directly measure disease progression in neurodegenerative diseases. He has a particular interest in functional imaging of implanted devices such as DBS. He currently has funding from the NIH as well as the State of Ohio to evaluate the efficacy of DBS therapy using functional MRI. Additionally, he has an interest in MRI safety of implanted electoral devices with patents for methods to develop MRI safe implanted electoral devices.
J. Theodore Phillips MD PhD
Dr. Phillips graduated with honors from the University of Texas at Austin, and subsequently received MD and PhD (Immunology) degrees from the University of Texas Southwestern Medical Center. From 1984 – 1993, he was director of the MS Center at UT Southwestern, and has been director of the MS Clinical and Research Center at Texas Neurology in Dallas since 1993. Dr. Phillips is also a faculty member of the Multiple Sclerosis Comprehensive Treatment Training Program at UT Southwestern. He has served for many years on the clinical advisory committee of the Lone Star MS chapter and additionally is a member of the national medical advisory board of the National MS Society. Dr. Phillips has participated in many phase II and III research studies involving new treatment strategies in MS; in several of these, he has served in advisory or steering committee capacities. Dr. Phillips is a frequent lecturer to professional and patient groups, and has authored or co-authored numerous peer-reviewed publications in neurology and immunology relating to MS. Dr. Phillips has been selected among the "Best Doctors in Dallas" by D Magazine, Dallas, "Best Doctors in Texas" by Texas Monthly magazine, and "Best Doctors in America."
Michael K. Racke M.D.
Michael K. Racke received his M.D. from the University of Medicine and Dentistry of New Jersey-New Jersey Medical School. He completed his neurology training at Emory University in Atlanta and a neuroimmunology fellowship at the National Institutes of Health. His first faculty position was at Washington University in St. Louis, where he was the recipient of a Harry Weaver Neuroscience Junior Faculty Award from the National Multiple Sclerosis Society and the Young Investigator in Multiple Sclerosis of the American Academy of Neurology Education and Research Foundation. He then moved to the University of Texas Southwestern Medical Center where he was Vice Chairman for Neurology Research and also professor in the Center for Immunology. In July, 2006, he assumed the chairmanship of neurology at The Ohio State University School of Medicine. His research focuses on understanding how inflammation gets established in the central nervous system and developing novel therapeutics by studying the animal model experimental autoimmune encephalomyelitis. His research also centers on the pathogenesis of multiple sclerosis. Dr. Racke has served on scientific advisory committees for the National Multiple Sclerosis Society, National Institutes of Health, and the Hertie Foundation as well as on several editorial boards.
Stephen M. Rao, MD, PhD
Stephen M. Rao, MD, PhD, a board-certified clinical neuropsychologist, is a professor of neurology at the Medical College of Wisconsin in Milwaukee. He obtained his PhD in clinical psychology from Wayne State University in Detroit and completed a predoctoral internship at Rush-Presbyterian-St. Luke's Medical Center in Chicago. For the past two decades, he has conducted longitudinal investigations of the cognitive, personality, and neuroimaging changes associated with multiple sclerosis. He has also been involved in the development of cognitive tests for measuring outcome in MS clinical trials. He has authored more than 80 scientific papers and book chapters and edited three books, including Neurobehavioral Aspects of Multiple Sclerosis, published by Oxford University Press. Dr. Rao has been a recipient of an NIH Research Career Development Award and has received funding from the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health, the Charles A. Dana Foundation, and the National Multiple Sclerosis Society. He is associate editor of The Journal of the International Neuropsychological Society. He reviews articles for more than 30 journals and grants for the National Institutes of Health, National Multiple Sclerosis Society, and the Veterans Administration. He was recently elected a fellow of the American Psychological Association.
Anthony T. Reder, MD
Anthony T. Reder, MD, is an associate professor of neurology at the University of Chicago School of Medicine. He earned is BS in psychology and zoology and his MD at the University of Michigan. He also served his residency in Neurology at Michigan, and he served his fellowship in neuroimmunology at the University of Chicago. Dr. Reder is the chairman of the clinical advisory committee for the Chicago and Greater Illinois chapter of the National MS Society (NMSS), and he is a consultant for the NMSS professional research center. Dr. Reder is the author or co-author of numerous articles, abstracts, book chapters, and he is the author of Interferon Therapy in Multiple Sclerosis. In 2003 he was listed in the "Best Doctors in Chicago" by Chicago Magazine.
Syed Rizvi, MD In addition to his position as a clinical assistant professor of clinical neurosciences at Brown Medical School, Syed Rizvi, MD, is the director of the Multiple Sclerosis Center at Rhode Island Hospital, and serves on the medical staff for Rhode Island Hospital, Women and Infants Hospital, and Newport Hospital. Dr. Rizvi earned his MD at Dow Medical College, and completed his residency and his fellowship in neuroimmunology and multiple sclerosis at Stony Brook University Hospital of the State University of New York.
Amy Perrin Ross, RN, MSN, CNRN
Amy Perrin Ross, RN, MSN, CNRN, is the neuroscience program coordinator at Loyola University Medical Center in Maywood, Illinois. In this role she serves as the coordinator for the Multiple Sclerosis Center. For the past 18 years she has worked extensively with MS clients and families. Ms. Ross is a clinical consultant for the National Multiple Sclerosis Society (NMSS) and a member of the clinical advisory committee for the Greater Illinois Chapter of the NMSS. She is also a past president of the American Association of Neuroscience Nurses and is a founding director of the International Organization of Multiple Sclerosis Nurses. In 1977, Ms. Ross obtained her BS in nursing from Loyola University of Chicago. She completed her MS in 1982 at Loyola University of Chicago and is currently completing her PhD at the University of Illinois. Ms. Ross has presented lectures nationally and internationally to health care professionals and clients.
Randall T. Schapiro, MD Randall T. Schapiro, MD, was born and raised in Minnesota. After graduating from Occidental College in Los Angeles, in biology, he graduated from the University of Minnesota Medical School. He trained in internal medicine at the Wadsworth VA Medical Center (UCLA) in Los Angeles and in neurology under A. B. Baker, MD, at the University of Minnesota. Following a short stint as a faculty member and director of the MS clinic at the University of Minnesota, he founded the first comprehensive MS center, The Fairview MS Center, in 1977, which was renamed The Schapiro Center for Multiple Sclerosis at the Minneapolis Clinic of Neurology in 2004. He was the first elected president of the consortium of MS centers, an organization which he helped found. He has participated in the development of the Heuga Center, a wellness center for MS based in Colorado, and was given their Can Do award. He has been elected to the National Multiple Sclerosis Society Hall of Fame and has served on numerous advisory committees for them, including the Medical Advisory Board. He also serves on the International Multiple Sclerosis Society's Medical Advisory Board. He has served on the National Board of the National Multiple Sclerosis Society for three years, and he is serving his 29th year on the local board of the National Multiple Sclerosis Society. He has lectured and written extensively, nationally and internationally, on all topics associated with MS management. While he has participated in numerous research studies, he is best known for his educating and patient management style, often using humor to teach sensitive topics.
Jan Schilling, BSN, CRRN, MSCN
Jan Shilling, BSN, CRRN, MSCN, is the multiple sclerosis clinical nurse for the Western Multiple Sclerosis Center at the University of Washington Medical Center in Seattle. She is a multiple sclerosis-certified nurse on the clinical faculty for the department of rehabilitation medicine and a member of the MS Research and Training Center Board at the University of Washington. Ms. Schilling serves on the professional advisory committee for the Western Washington chapter of the National Multiple Sclerosis Society and also is a board member of the International Organization of Multiple Sclerosis Nurses.
Nilay Shah, MD
Director, Neurology Division Dr. Nilay Shah was born and raised in Buffalo, NY. After getting his undergraduate degree at Cornell University and finishing medical school at St. George's University, Dr. Shah went on to a Neurology Residency at Mt. Sinai Medical Center. He completed a Neurophysiology Fellowship at the University of Pittsburgh then went into private practice in Upstate NY. For nearly 3 years, Dr. Shah ran a clinic for patients with Multiple Sclerosis about 60 miles northwest of New York city. Dr. Shah is now in private practice in the metro New York area. He is a founding member and Director of Communications for the New York State Neurological Society, and also sits on the Advisory Board for the MS Society of Southern NY State. Dr. Shah also teaches Neurology as an Assistant Professor in Neurology at St. George's University School of Medicine. His other interests include the use of technology in healthcare, and he's given a number of lectures at medical society meetings around the country as co-founder and CIO of MedicalPocketPC.com, the internet's leading website for healthcare professionals using handheld technology to improve patient care. Dr. Shah enjoys traveling, having visited over 60 countries over the last 20 years, and is also an avid bicyclist and downhill skier.
Jack Simon, MD
Derek Smith, MD
Derek Smith, MD, is a board-certified neurologist who practices neurology at Massachusetts General Hospital and Brigham and Women's Hospital in Boston. In addition, he is a clinical instructor in neurology at Harvard Medical School. A practicing physician, Dr. Smith treats patients with multiple sclerosis and other demyelinating disorders. At present, Dr. Smith conducts research in the area of demyelinating disorders, especially with respect to the central nervous system, with grants from the National Multiple Sclerosis Society and the National Institutes of Health. Dr. Smith's neuroimmunology research is conducted at the Brigham and Women's Hospital, a research laboratory that is as large or larger than the neuroimmunology laboratory housed at the National Institutes of Health. He has published several articles about the immunology of central nervous system demyelinating disorders and a book chapter about the epidemiology of multiple sclerosis.
Subramaniam Sriram, MD
Subramaniam Sriram, MD, is the William Weaver Professor of Experimental Neurology at the Vanderbilt University Medical Center and professor of microbiology and immunology also at Vanderbilt. In addition, he is director of the Multiple Sclerosis Clinic at Vanderbilt. Dr. Sriram received his MD from the University of Madras in Madras, India. He completed a residency in internal medicine at Wayne State University after which he went on to do a residency in neurology at Stanford University where he was chief resident. He then completed a fellowship in neuroimmunology also at Stanford. Dr. Sriram is board certified in both internal medicine and neurology. Dr. Sriram has received a number of awards throughout his career, including the National Research Service Award in Neuroimmunology from the NIH and the Education Award from the National MS Society. He is a board member of the National MS Society. He is an associate editor for The Journal of Immunology. He also has authored over 94 articles in peer-reviewed journals.
Dusan Stefoski, MD
Dusan Stefoski, MD, a board-certified neurologist since 1980, is an Associate Professor of Neurology at the Rush University Medical College, a Senior Attending Neurologist at the Rush-Presbyterian-St. Luke's Medical Center, and the Director of the Rush Multiple Sclerosis Center in Chicago. Dr. Stefoski received the medical degree and concluded the internship at the University of Zagreb Medical School in Croatia (formerly Yugoslavia). He completed his neurology residency at Rush, and his training in neuropathology at Stanford University. Dr. Stefoski, a Fellow of the American Academy of Neurology, has been doing novel research in the field of multiple sclerosis at Rush, and has been participating in collaborative projects with researchers in the United States and internationally. In association with Dr. Floyd Davis, he pioneered the proof-of-concept and efficacy of 4-aminopyridine in multiple sclerosis. He teaches and lectures nationally and internationally.
James Stevenson, MD, PhD
A board-certified neurologist in practice since 1994, James Stevenson, MD, PhD, received his BS in biology from the Massachusetts Institute of Technology and his PhD for work in developmental neurobiology from Dalhousie University in Nova Scotia in 1980. He then continued basic science research in brain development and regeneration until leaving his position as associate professor of anatomy at the Medical College of Virginia to attend medical school. He graduated from the University of Miami School of Medicine. Dr. Stevenson completed both his internship in internal medicine and his residency in neurology at the University of South Florida School of Medicine, where he served as chief resident in neurology.
William H. Stuart, MD
William H. Stuart, MD, graduated from Northwestern University Medical School in 1961. Following an internship at Cleveland Metropolitan General Hospital, Dr. Stuart returned to Northwestern University where he completed an internal medicine residency. He subsequently served as an epidemic intelligence service officer at the Communicable Disease Center in Atlanta for two years following which he completed a three-year fellowship in neurology at Emory University Medical School. Upon completion of this training, and serving at the NINDS he entered private practice in the Atlanta area forming the Atlanta Neurological Clinic, subsequently renamed The Peachtree Neurological Clinic in 1990. Dr. Stuart began his focused interest in multiple sclerosis in 1988 and developed the Multiple Sclerosis Comprehensive Care and Research Center at Shepherd Center in 1991. He resigned this position in January 2001 to become Medical Director of The MS Center of Atlanta and form the MS Foundation of Georgia and the MS Research of Georgia. Dr. Stuart has maintained a broad interest in education and has served as a clinical professor of neurology at Emory University Medical School since 1987. Dr. Stuart's board certification includes the American Board of Internal Medicine, American Board of Psychiatry and Neurology.
Bruce Trapp, PhD
Bruce D. Trapp, PhD, is the chairman of the department of neurosciences at the Lerner Research Institute, Cleveland Clinic Foundation and a professor of neurosciences at Case Western Reserve University and the Ohio State University. Dr. Trapp received his PhD in Anatomy from Loyola University Stritch School of Medicine in Chicago. He completed a postdoctoral fellowship in the laboratory of neuropathology and neuroanatomical sciences and the laboratory of molecular genetics at the National Institutes of Health (NIH) in Bethesda. Following his tenure at the NIH, Dr. Trapp assumed the position of assistant professor, and subsequently associate professor, of neurology at the Johns Hopkins University School of Medicine in Baltimore. Dr. Trapp's research involves the pathobiology of neurological disability in multiple sclerosis patients and the cellular and molecular biology of myelination in the central and peripheral nervous systems. Dr. Trapp has published over 135 peer-reviewed articles and over 20 book chapters. He is a member of the editorial boards of Glia, The Journal of Neuroscience Research, and Journal of Neurocytology. Dr. Trapp is the recipient of the Jordi Folch-Pi Award from the American Society of Neurochemistry, the Weil Award from the American Association of Neuropathologists, a Harry Weaver Neuroscience Scholar Award from the National Multiple Sclerosis Society (NMSS), the Jacob Javits Award in Neuroscience from the National Institute of Neurological Disorders and Stroke, and this year he was awarded the John Dystel Prize for MS Research from the American Academy of Neurology.
Timothy Vartanian, MD, PhD
Timothy Vartanian, MD, PhD, received his MD and PhD from the University of Chicago. He completed his neurology residency at Massachusetts General Hospital and his research fellowship with the department of neurology at Harvard Medical School. He is the director of the Multiple Sclerosis Center and chief of the division on demyelinating disease at Beth Israel Deaconess Medical Center in Boston. He is an associate professor of neurology at Harvard Medical School. He is also chief scientist and cofounder of the Boston Cure Project for Multiple Sclerosis, a nonprofit organization devoted to supporting research in multiple sclerosis.
Ulrich H. von Andrian, MD, PhD
Ulrich H. von Andrian, MD, PhD, is an associate professor of pathology at Harvard Medical School, and an investigator at the Center for Blood Research. He earned his MD and his PhD in Neurology/Neurosurgery at the Ludwig-Maximilians University in Munich, Germany. Dr. von Andrian is the author or co-author of 78 publications. He is a member of the Microcirculatory Society, the American Association of Immunologists, the North American Vascular Biology Organization, the America Association of University Pathologists, the American Society for Investigative Pathology and the European Academy of Sciences. He also serves on the editorial boards of Microcirculation, The American Journal of Physiology: Heart and Circulation Physiology, and The Journal of Experimental Medicine.
Howard Weiner, MD
Howard Weiner, MD, is the Robert L. Kroc Professor of Neurology at the Harvard Medical School and director of the Multiple Sclerosis Center at the Brigham and Women's Hospital and the Massachusetts General Hospital. He is also co-director of the Center for Neurologic Diseases at the Brigham and Women's Hospital. Dr. Weiner attended Dartmouth College and received his MD from the University of Colorado School of Medicine. He obtained his neurology training at the Harvard Longwood neurology program. He has investigated basic and clinical aspects of autoimmunity in MS for the past 25 years. Dr. Weiner has pioneered the understanding of the mucosal immune system and how antigens, which are administered orally or nasally, may be used to modulate autoimmune and other inflammatory diseases. Based on his work, oral vaccines have been tested not only in MS, but also in diabetes and arthritis. The current trial of orally administered Copaxone to patients with MS is based on Dr. Weiner's basic work on oral tolerance. As part of Dr. Weiner's clinical investigations, he completed a major study of MRI imaging in MS and demonstrated linkage of MRI abnormalities with different stages of MS. This resulted in a dynamic picture of the disease, which had not previously been observed.
Jeffrey A. Wilken, PhD Dr. Jeffrey Wilken is an Assistant Professor of Neurology at the Georgetown University Medical Center. He is also Director of the Washington Neuropsychology Research Group and Director of Research at Neuropsychology Associates of Fairfax. Dr. Wilken received his B.S. from Cornell University, and his M.A. and Ph.D. from the University of Maryland at College Park. He completed pre-doctoral training at the NIH, Walter Reed Army Medical Center, Johns Hopkins Outpatient Center, and the VA Medical Center in Baltimore, MD. He completed post-doctoral training at Georgetown University Medical Center. Dr. Wilken is currently the primary investigator in charge of multi-center, funded studies looking at the cognitive sequelae of multiple sclerosis (MS), the utility of computerized assessment for patients with MS, and the efficacy of combination therapy in the treatment of breakthrough cognitive problems in MS patients. He has authored numerous peer-reviewed journal publications and published abstracts. His research has been presented at national and international scientific conferences, including: American Neurological Association, American Academy of Neurology, and the Consortium of Multiple Sclerosis Centers. Dr. Wilken is a member of the American Academy of Neurology, Consortium of Multiple Sclerosis Centers, National Academy of Neuropsychology, International Neuropsychological Society, and American Psychological Association. He is also on the clinical advisory board for the Washington, D.C. chapter of the National Multiple Sclerosis Society and he is a reviewer for a number of scientific journals.
Jerry S. Wolinsky, MD
Jerry S. Wolinsky, MD, is the Bartels Family Professor of Neurology and a member of the graduate faculty of the Graduate School of Biomedical Sciences at The University of Texas Health Science Center at Houston. There he directs the Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center. Dr. Wolinsky received his MD from the University of Illinois in 1969. Residency training in clinical neurology, a fellowship in experimental neuropathology and faculty appointment at the University of California at San Francisco followed. While in San Francisco his research interests concentrated on the pathogenesis of viral infections of the nervous system, and his clinical efforts began to focus on experimental therapeutics of infections of the central nervous system and multiple sclerosis. He subsequently joined the faculty of the Johns Hopkins University Schools of Medicine, and Hygiene and Public Health in 1978 before settling in Houston in 1983. In Baltimore he applied more molecular tools to his basic investigations and became more interested in the primary and secondary immunopathogenesis of neural disease. He is currently is active in the design, implementation, conduct and analysis of clinical trials of multiple sclerosis and conducts basic and applied research in quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in demyelinating diseases. He has served on review and advisory committees of the National Institutes of Health, the National Multiple Sclerosis Society, the Multiple Sclerosis International Federation, the Food and Drug Administration, numerous pharmaceutical houses and the recently established Sylvia Lawry Centre for Multiple Sclerosis Research. He is an associate editor of Scientific American Medicine and is on the editorial board of Multiple Sclerosis: Clinical and Laboratory Research. He has authored numerous publications dealing with issues of relevance to neurovirology and neuroimmunology, clinical trials and the imaging of multiple sclerosis. |
 |
| |
| Resources | About Us | Contact Us | Privacy Policy | Disclaimer | Editorial & Sponsorship Policy | Terms of Use |
|